Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ascentage Pharma Group International (HK:6855)
HKEX:6855
Holding HK:6855?
Track your performance easily
6855 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$15.42 - HK$48.85
Previous CloseHK$42.55
Volume1.76M
Average Volume (3M)2.35M
Market Cap
HK$13.29B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.14
Next Earnings
Mar 26, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.35
Shares OutstandingN/A
10 Day Avg. Volume1,743,675
30 Day Avg. Volume2,347,122
Standard Deviation0.21
R-Squared0.18
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)35.52
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$40.00Price Target Upside-5.99% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Ascentage Pharma Group International News
PremiumCompany Announcements
Ascentage Pharma Enhances Board with Strategic Appointments
PremiumCompany Announcements
Ascentage Pharma Announces Board Roles and StructurePremiumCompany Announcements
Ascentage Pharma’s Lisaftoclax Advances in Drug Approval
PremiumCompany Announcements
Ascentage Pharma Showcases Promising Drug Developments
PremiumCompany Announcements
Ascentage Pharma Adjusts RSU Schemes for Strategic GainsPremiumCompany Announcements
Ascentage Pharma’s APG-2449 Advances to Phase III
PremiumCompany Announcements
Ascentage Pharma Issues New Employee RSUs
PremiumCompany Announcements
Ascentage Pharma Reports Soaring H1 2024 RevenueOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
1.70% Mutual Funds
― Other Institutional Investors
95.42% Public Companies and
Individual Investors
6855 FAQ
What was Ascentage Pharma Group International’s price range in the past 12 months?
Ascentage Pharma Group International lowest stock price was HK$15.42 and its highest was HK$48.85 in the past 12 months.
What is Ascentage Pharma Group International’s market cap?
Currently, no data Available
When is Ascentage Pharma Group International’s upcoming earnings report date?
Ascentage Pharma Group International’s upcoming earnings report date is Mar 26, 2025 which is in 119 days.
How were Ascentage Pharma Group International’s earnings last quarter?
Ascentage Pharma Group International released its earnings results on Aug 22, 2024. The company reported HK$0.591 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.591.
Is Ascentage Pharma Group International overvalued?
According to Wall Street analysts Ascentage Pharma Group International’s price is currently Overvalued.
Does Ascentage Pharma Group International pay dividends?
Ascentage Pharma Group International does not currently pay dividends.
What is Ascentage Pharma Group International’s EPS estimate?
Ascentage Pharma Group International’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ascentage Pharma Group International have?
Ascentage Pharma Group International has 315,203,950 shares outstanding.
What happened to Ascentage Pharma Group International’s price movement after its last earnings report?
Ascentage Pharma Group International reported an EPS of HK$0.591 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.179%.
Which hedge fund is a major shareholder of Ascentage Pharma Group International?
Currently, no hedge funds are holding shares in HK:6855
---
Ascentage Pharma Group International Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
73.67%
12-Months-Change
Fundamentals
Return on Equity
-53.25%
Trailing 12-Months
Asset Growth
6.05%
Trailing 12-Months
Company Description
Ascentage Pharma Group International
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis, or programmed cell death. The company's geographical segments include the United States and Mainland China.
---
6855 Stock 12 Month Forecast
Average Price Target
HK$40.00
▼(-5.99% Downside)
Technical Analysis
Viva Biotech Holdings
―
TOT BIOPHARM International Co. Ltd.
―
Akeso, Inc.
―
Petro-king Oilfield Services Ltd.
―
Best Analysts Covering 6855
1 Year
1 Year Success Rate
2/3 ratings generated profit
1 Year Average Return
+9.00%
reiterated a buy rating 3 months ago
Copying Chris Lui's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +9.00% per trade.
---